Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Gufic Biosciences Ltd - 509079 - Closure of Trading Window

 Pursuant to the National Stock Exchange of India Limited (NSE) letter dated 2nd April, 2019 vide Ref. No: NSE/CML/2019/11 and in accordance with the Company''s Code of Conduct, framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, please be informed that the trading window shall be closed for dealing in the securities of the Company for all the Insiders (including Directors and Connected/ Designated Persons and their immediate relatives) of the Company from Wednesday, 3rd April, 2019. The trading window will re-open 48 hours from the announcement to the Stock Exchanges of the Financial Results of the Company for the Financial Year ended 31st March, 2019. Kindly take the same on record.
03-04-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Cessation

 Pursuant to Regulation 17 (1A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Mr. Sharat Shantilal Gandhi (DIN: 00001730) , Independent Director of the Company , aged 79 years, shall cease to be a Director of the company with effect from April 01 2019. Kindly take the same on record.
30-03-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 We wish to inform you that pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 ('the Regulations'), the Company has adopted/amended the following codes/policies effective from 1st April, 2019:- i. Code of Fair Disclosure, which includes Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI); Policy for Regulating, Monitoring and Reporting of Trading by Insiders and Policy for inquiry in case of leak of Unpublished Price Sensitive Information (UPSI). ii. Policy on Determination of Legitimate Purpose. As required under the Regulations, the aforesaid code and policy are placed on the website of the Company at http://gufic.com/wp-content/uploads/2016/08/CodeofFairDisclosure.pdf and http://gufic.com/wp-content/uploads/2016/08/PolicyonDeterminationofLegitimatePurpose.pdf respectively. Kindly take the same on record.
30-03-2019
Bigul

Gufic Biosciences Ltd - 509079 - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

 With reference to the captioned subject, we hereby inform that the Board of Directors of the Company at its Meeting held today i.e. March 25, 2019, inter alia approved the Scheme of Amalgamation of Gufic Lifesciences Private Limited with the Company and their respective shareholders and creditors ('Scheme'). The above Scheme is in substitution of the Scheme intimated vide letter dated September 20, 2018 to the Stock Exchanges and the revision is due to change in shareholding pattern of Gufic Lifesciences Private Limited. The details as required under SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 is enclosed herewith as Annexure 'A'. The Meeting commenced at 05.00 p.m. and concluded at 07.45 p.m. Kindly take the same on record.
25-03-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Gufic Biosciences Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
14-03-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Postal Ballot - Submission Of Details Regarding Voting Results Of The Postal Ballot As Per The Format Prescribed Under Regulation 44 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to the above captioned subject, we enclose herewith the results of voting of the Members of the Company, conducted by way of postal ballot (including electronic voting) as per the format prescribed under the provisions of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with this letter. Also enclosed is the copy of the Consolidated Scrutinizers Report submitted by the Scrutinizer on e-voting and postal ballot. Please note that the Resolution has been passed with requisite majority as prescribed under applicable laws. Kindly take the same on your record.
14-03-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBI Funds Management Pvt Ltd
25-02-2019
Bigul

Gufic Biosciences Ltd - 509079 - Announcement Under Regulation 30 Of The SEBI(Listing Obligations & Disclosure Requirements) Regulations, 2015.

 With reference to our earlier announcement about the outcome of the Board Meeting held on February 13, 2019, regarding the Un-audited Financial Results of the Company for the quarter and nine months ended on December 31, 2019, kindly find enclosed the Management Report for Q3 FY2018-19.
14-02-2019
Bigul

GUFIC BIOSCIENCES LTD. - 509079 - Outcome Of The Board Of Directors Meeting Held For The Quarter And Nine Months Ending December 31, 2018

 Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on 13th February, 2019 inter alia considered and approved the Un-audited Financial Results of the Company for the Quarter and Nine months ended December 31, 2018. In terms of provisions of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following: a. A copy of the Un-Audited Financial Results for the Quarter and Nine months ended December 31, 2018. b. Limited Review Report received from the Statutory Auditor of the Company on the Un-Audited Financial Results for the Quarter and Nine months ended December 31, 2018.
14-02-2019
Bigul

Gufic Biosciences Ltd - 509079 - Postal Ballot - Submission Of Newspaper Advertisement About Dispatch Of Postal Ballot Notice

 Pursuant to the provisions of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit copy of newspaper advertisement published on 10th February, 2019 in newspapers viz. Business Standard (in English Edition) and Mumbai Lakshadeep (in Marathi Edition) inter alia informing about the dispatch of Postal Ballot Notice dated 1st February, 2019, e-voting facility offered to the Members of the Company, Cut-off Date and matters related thereto. The same is also made available on website of the Company at www.gufic.com. Kindly take the same on your record.
11-02-2019
Next Page
Close

Let's Open Free Demat Account